General Healthtech

Aetherus tackles COPD, a debilitating lung disease, with their portable, non-invasive (pNIV) device. This device offers instant relief from breathlessness, improving patients' daily lives without adding to treatment regimens or causing side effects. By empowering patients to manage breathlessness anytime, anywhere, the pNIV device enhances COPD management and quality of life. This not only benefits patients but also alleviates the burden on healthcare systems, families, employers, and society at large.

AIDO enhances precision control during endoscopic procedures with its drive unit. Physicians can now maintain control of the endoscope shaft while operating tools, saving time and improving efficiency. This platform technology streamlines the control of instruments inserted through the endoscope's working channel, offering automatic insertion and precise control, ultimately improving patient safety and procedural outcomes.

Allergios revolutionizes allergy diagnosis by directly visualizing the allergic response in patient blood, offering a more accurate alternative to current tests like skin prick and IgE blood tests. Additionally by analyzing how blood serum reacts to allergens. With its disposable chip, optical reader, and AI-based analysis software, Allergios helps millions of allergy sufferers worldwide access timely and effective treatment options.

Angiogenesis Analytics, offers an ultrasound-based solution for detecting, localizing, and characterizing prostate cancer. Each year, over 1.5 million men undergo invasive biopsies with risks of infection, false negatives, and overtreatment. Angiogenesis Analytics eliminates these issues by providing a non-invasive, accurate, and cost-effective alternative, improving patient comfort and outcomes. With an estimated market value of USD 450 million annually, Angiogenesis Analytics addresses a significant global need for better prostate cancer diagnostics.

Ansana offers a smart sterilization container for surgical instruments, designed to tackle key challenges in the healthcare sector. By integrating electronic sensors, it ensures sterility in operating rooms, reducing the risk of infections by 10% and lowering the environmental impact of sterilization processes by 85%. Ansana's enhances patient safety with real-time monitoring and traceability features, with complex instruments like endoscopes, while also cutting costs for healthcare facilities in terms of labor and materials.

Arne enhances urgent neonatal care by using augmented reality and artificial intelligence to provide real-time clinical decision support. In stressful situations, doctors can miss critical protocol steps, but Arne’s smart software projects recommends actions directly into the doctor's field of vision, reducing errors and improving patient outcomes. This innovative tool ensures every newborn receives optimal care, while empowering neonatologists.

The rising number of surgeries in healthcare systems like the National Health Service is challenging due to increasing demand and backlogs. However, new solutions like the Asclepius Platform aim to streamline assessments before and after surgery using digital tools and AI. By analyzing patient data, it helps doctors make better decisions, reduce complications, and improve patient outcomes. Designed with input from patients, it's a cost-effective way to make surgery safer and more efficient.

Aspect Neuroprofiles is tackling the challenges of diagnosing and treating Autism Spectrum Disorder (ASD) by combining EEG technology with Artificial Intelligence. Their method objectively measures brain activity related to ASD, improving diagnosis accuracy and predicting treatment effectiveness. This approach aims to shift from subjective assessments to objective physiological measurements, offering hope for millions affected by ASD and mental health issues.

Bilihome aims to revolutionize jaundice treatment for newborns by bringing safe and effective phototherapy from the hospital to the comfort of home. Currently, traditional methods require babies to be isolated in hospitals, disrupting bonding and caregiving between parents and infants. Bilihome's solution integrates blue light therapy into a comfortable garment, allowing newborns to receive treatment while being held, breastfed, and cared for as usual. This patient-centered innovation enables natural care at home, freeing up hospital bed space and promoting family-centric care.

BiteOn has devised a breakthrough in dental implants: personalized implants tailored to each patient's jawbone structure. Traditional bone graft procedures are costly and painful, often extending treatment time by six months. BiteOn's solution eliminates the need for bone grafts by designing implants based on 3D scans of the patient's mouth. This innovation promises quicker, less painful, and more successful dental replacements, offering hope to patients previously unable to undergo traditional procedures.

Capnosway introduces a CO2 monitoring device designed to address the shortcomings of traditional anesthesia. Developed by Philips, this solution directly measures CO2 concentration at the patient's mouth or nose without the need for air sampling. By eliminating procedures, and potential errors associated, Capnosway ensures accurate and efficient monitoring for medical professionals.

ChARM, or the Children’s Automated Respiration Monitor, addresses the challenge of pneumonia misdiagnosis in low-resource settings. This battery-powered device provides accurate breathing rate monitoring for children under five, empowering healthcare workers to make correct diagnoses swiftly. By streamlining the diagnostic process, ChARM facilitates timely treatment, potentially saving thousands of young lives annually.

The traditional practice of immediately cutting the umbilical cord after birth can pose risks to newborns, causing a dangerous drop in blood flow and oxygen levels. Concord Neonatal offers a solution by allowing babies to receive lifesaving care with the umbilical cord intact until they start breathing on their own. This innovation, aims to prevent birth complications and long-term disabilities, while keeping the baby close to the mother and maximizing the benefits of placental blood until the baby can breathe independently.

Crainio pioneers intracranial pressure (ICP) monitoring, for assessing traumatic brain injuries (TBI) without invasive procedures. Traditional methods involve drilling into the skull, posing risks. Crainio's method uses a forehead probe and a technique called photoplethysmography to measure pulse signals. This gives real-time estimates of ICP without invasive procedures. With TBI being a leading cause of death and disability, Crainio's innovation will potentially revolutionize TBI management.

Ecomedic is dedicated to helping hospitals reduce their carbon footprint, addressing the healthcare sector's contribution to global emissions. Ecomedic's database and software tools enable environmental impact analyses, identify sources of emissions and measures the effect of alternative solutions. By providing insights and solutions, the institutions are supported in achieving their carbon neutrality goals and reducing operational costs.

Flash Pathology revolutionizes tissue assessment with its scanner, with immediate imaging of biopsy and surgical specimens in the moment of operation. Unlike traditional methods, taking hours and requiring extensive labor, the Flash Pathology scanner visualizes cell structures within seconds without any preparation. This, non-labor-intensive solution enables distinguishing healthy tissue from tumors in real-time, reducing the need for revision surgeries and unnecessary biopsies.

FlowView Diagnostics addresses the challenge of analyzing complex cell data from blood samples using multiparameter flow cytometry, vital for conditions like leukemia monitoring. They tackle this with an algorithm that quickly processes raw data, detecting Minimal Residual Disease (MRD) more accurately and rapidly than manual methods. In a case study, the algorithm analyzed 8 million cells in 2 minutes, presenting simplified results for quicker interpretation, reducing the risk of false negatives, and enhancing efficiency in leukemia monitoring.

Foveo Fertility addresses the challenge of improving in vitro fertilization (IVF) success rates by providing a stable physiological environment for egg cells. Unlike current methods that expose egg cells to air, leading to cooling and evaporation, Foveo Fertility ensures consistent conditions for optimal egg cell quality. This innovation also streamlines workflow in the IVF lab, reducing human error and saving time for embryologists. With no other product on the market offering constant physiological conditions for egg cells, Foveo Fertility aims to improve the lives of both lab workers and patients by maximizing the potential for successful pregnancies.

Heat2Move offers a revolutionizing approach to chronic back pain treatment. Unlike traditional methods relying on medications or heat patches, Heat2Move combines blue light and infrared warmth to enhance blood flow and muscle repair. This innovative solution provides therapists and patients with a new tool for managing chronic pain effectively. With its potential to make a significant impact on treatment options, BlueTouch offers hope for those suffering from back pain worldwide.

Hemeo addresses the challenge of treating ICU patients with coagulation issues by developing a decision support system. This system uses patient data and real-time monitoring to accurately assess bleeding and thrombosis risks. By modeling the coagulation system with a smart algorithm, it provides personalized recommendations to clinicians, helping them make more informed therapy decisions. With ICU patients at high risk for venous thromboembolism and bleeding incidents, this solution aims to improve patient outcomes and reduce uncertainty in treatment.

Innofuse is revolutionizing care for the most fragile among us: preterm infants in Neonatal Intensive Care Units (NICUs). Their innovative Tulive® IV-set ensures these tiny patients receive medication with precision and immediacy, sparing them from the risks of inaccurate or delayed drug administration. By reducing fluctuations and eliminating overshoot, Tulive® safeguards against potential brain damage, offering hope and reassurance to families in NICUs worldwide.

Intuescope, develops advanced tools to make endoscopy and colonoscopy procedures faster and safer. Despite being gold standard tests, traditional scopes have changed little over 40 years and often miss abnormalities. Intuescope's innovations aim to reduce procedure time, enhance detection accuracy, and support doctors with more automation, addressing the growing need for efficient and reliable endoscopic solutions.

Introducing LarynxLock, prevents air leaks during surgery with a gentle pressure on the mouth's base, ensuring patients receive uninterrupted air supply. LarynxLock not only safeguards patients from complications but also reduces physical strain and surgery duration, offering a smart and cost-effective solution for improved surgical outcomes.

Laparoscopic surgery, while effective, faces limitations in low-resource areas due to cost and sustainability concerns associated with CO2 insufflation. Gasless laparoscopy provides an alternative, that are costly and difficult to use. To address these challenges, LORESA has developed an affordable and user-friendly gasless laparoscopy retractor, designed with input from surgeons worldwide, offering improved usability and cost-effectiveness. This innovation, aims to democratize laparoscopic techniques, benefiting rural hospitals and developing communities.

MindAffect aims to diagnose visual and hearing impairments in over 2 billion people, including children, seniors, and the disabled, leading to untreated impairments and significant societal costs. Their innovative brain computer interface and AI technology offer a solution by analyzing brain responses to auditory or visual stimuli, reducing testing time and improving accuracy.

OSTEOWELD introduces an ultrasonic welding system for bone fractures. Unlike traditional methods with limited fixation options, OSTEOWELD welds polymer-based screws directly to bone or metal implants using high-frequency vibrations. This innovative approach offers more versatility, shorter procedure times, and reduced radiation exposure, making it ideal for complex fractures, especially around joints.

PEP Health addresses the complexity of monitoring healthcare quality by offering a platform that tackles key challenges in quality assessment. By combining multiple sources of patient feedback, including social media, PEP provides near real-time assessments of quality for hospitals and departments. This approach reduces costs, improves timeliness, and enhances trustworthiness compared to traditional methods. With potential customers ranging from healthcare providers to patient organizations, PEP's underlying algorithm has been validated across industries, including higher education.

Pasithea improves treating obstructive sleep apnea (OSA), a condition affecting millions worldwide. Traditional treatments like continuous positive airway pressure (CPAP) face high refusal and dropout rates. Pasithea offers a non-invasive solution based on triggered kinesthetic stimulation. By detecting early signs of apnea or hypopnea and inducing a controlled response, Pasithea activates muscle control centers to prevent oxygen desaturation and associated cardiovascular risks, aiming to improve patient compliance and outcomes.

Polynerve is a cutting-edge solution for repairing nerve injuries, offering a better alternative to traditional methods like autografting. Its unique design helps nerves grow in the right direction, reducing complications and surgical time. This absorbable option improves patient recovery and simplifies surgery for healthcare providers, making it a game-changer in nerve repair procedures.

The Pryfiber single multimode optical fiber endoscope, with an ultrathin diameter of less than 300 microns, uses an AI algorithm for real-time calibration to create accurate images. This minimally invasive technology allows for precise diagnostics and treatment in areas like joints, cardiac arteries, and neurosurgery, offering a safer and more effective alternative to traditional, more invasive methods.

Respiosa offers a groundbreaking solution for obstructive sleep apnea (OSA), a condition affecting millions worldwide. Unlike traditional treatments like CPAP or surgery, Respiosa provides a minimally invasive, surgically implanted solution specifically targeting tongue-based obstruction, a common cause of OSA. Developed by Philips, Respiosa promises effective, durable, and adjustable therapy with a quick recovery time. With its natural and unobtrusive design, Respiosa ensures high patient adherence, addressing a significant gap in OSA treatment options.

Retinacheck addresses the challenge of Diabetic Retinopathy, the leading cause of blindness in working-age adults, particularly in regions with poor access to eye care. With over 23% of China's 110 million diabetics affected, Retinacheck's solution becomes crucial. By utilizing retinal images captured by a fundus camera, their Convolutional Neural Network algorithm can diagnose Diabetic Retinopathy with over 94% accuracy, surpassing traditional methods.

Sansepsis is a new treatment for sepsis, a serious condition causing many hospital deaths. Developed by Sanquin, a top blood bank in Europe, it uses a special filtering technology called apheresis to remove harmful pathogens from the blood. This innovative approach aims to improve patient outcomes and reduce the high costs associated with treating sepsis, offering hope for better management of this deadly condition.

Scinvivo introduces a solution for bladder cancer diagnosis with its imaging catheter, providing real-time, cross-sectional tissue images. Traditional methods often lead to unnecessary surgeries and missed tumors. By utilizing Optical Coherence Tomography technology, Scinvivo's catheter offers high-resolution imaging, enabling urologists to accurately diagnose bladder conditions. This approach reduces unnecessary surgeries but also enhances diagnostic accuracy, improving patient outcomes.

SelfSafeSure's Blood Collection Assist Device (BCAD) revolutionizes at-home blood collection, offering a clean and reliable solution compatible with standard hospital analyzers. Developed by the Netherlands Cancer Institute, this device is ideal for monitoring conditions like infectious diseases, prostate cancer, and diabetes, SelfSafeSure's BCAD enhances early intervention and compliance while alleviating the burden on diagnostic centers.

Timelab addresses the challenge of ambulance delays in the Netherlands by offering a proactive solution through their Emergency Mathematics software. With 7% of ambulance arrivals exceeding the 15-minute target, 35,000 patients annually don't receive timely care, impacting mortality and morbidity rates. Timelab's software predicts future demand and facilitates the proactive relocation of ambulances, aiming to reach 95% of high emergency call locations within 15 minutes, compared to the current 93%.

Wavefront is revolutionizing live-cell imaging with their AI-driven computational microscope, offering a stain-free imaging technique powered by patented quantitative-phase-imaging (QPI) technology. This approach eliminates the need for costly and invasive chemical staining, preserving cell integrity with real-time visualization of cellular structures with precision and detail. Wavefront's innovative solution has transformative potential research across diverse fields, from cancer research to clinical diagnostics.